TIROSINT-SOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tirosint-sol, and when can generic versions of Tirosint-sol launch?
Tirosint-sol is a drug marketed by Institut Biochimique and is included in one NDA. There are two patents protecting this drug.
This drug has thirteen patent family members in eleven countries.
The generic ingredient in TIROSINT-SOL is levothyroxine sodium. There are ten drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tirosint-sol
A generic version of TIROSINT-SOL was approved as levothyroxine sodium by MYLAN on June 5th, 2002.
Summary for TIROSINT-SOL
| International Patents: | 13 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 63 |
| Clinical Trials: | 7 |
| Patent Applications: | 3,045 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for TIROSINT-SOL |
| DailyMed Link: | TIROSINT-SOL at DailyMed |
Recent Clinical Trials for TIROSINT-SOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Cromsource | Phase 4 |
| University of California, Los Angeles | Phase 4 |
| Children's Mercy Hospital Kansas City | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for TIROSINT-SOL
US Patents and Regulatory Information for TIROSINT-SOL
TIROSINT-SOL is protected by two US patents.
Patents protecting TIROSINT-SOL
High-stability packaged solutions of T4 thyroid hormone
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
High-stability packaged solutions of T4 thyroid hormone
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Institut Biochimique | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-001 | Dec 15, 2016 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| Institut Biochimique | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-008 | Dec 15, 2016 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| Institut Biochimique | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-011 | Dec 15, 2016 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| Institut Biochimique | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-003 | Dec 15, 2016 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for TIROSINT-SOL
See the table below for patents covering TIROSINT-SOL around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Russian Federation | 2765547 | ВЫСОКОСТАБИЛЬНЫЕ УПАКОВАННЫЕ РАСТВОРЫ ТИРЕОИДНОГО ГОРМОНА Т4 (HIGHLY STABLE PACKAGED SOLUTIONS OF THE THYROID HORMONE T4) | See Plans and Pricing |
| European Patent Office | 3528847 | SOLUTIONS CONDITIONNÉES À STABILITÉ ÉLEVÉE D'HORMONE THYROÏDIENNE T4 (HIGH-STABILITY PACKAGED SOLUTIONS OF T4 THYROID HORMONE) | See Plans and Pricing |
| World Intellectual Property Organization (WIPO) | 2018073209 | See Plans and Pricing | |
| Denmark | 3528847 | See Plans and Pricing | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2022 - 2023
NCE-1 Patent Challenge Dates 2022 - 2023
ClinicalTrialExchange - Connecting volunteers and trials
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2022, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
